In accordance with section l0(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting.
Name: CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment.
Times and Dates: 8:30 a.m.—5 p.m., May 15, 2003.
8:30 a.m.—12 p.m., May 16, 2003.
Place: Sheraton Colony Square Mid-Town, 188 14th Street at Peachtree, Atlanta, Georgia 30361
Status: Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people.
Purpose: This Committee is charged with advising the Secretary, HHS, the Director, CDC, and the Administrator, HRSA, regarding activities related to prevention and control of HIV/AIDS and other STDs, the support of health care services to persons living with HIV/AIDS, and education of health professionals and the public about HIV/AIDS and other STDs. The Committee will support the Agencies' process of identifying and responding to the prevention and health service delivery needs of affected communities, and the needs of individuals living with or at risk for HIV and other STDs.
Matters To Be Discussed: Agenda items include issues pertaining to (1) HIV and STD prevention for Men Who Have Sex With Men (MSM) (2) AIDS Drug Assistance Program (ADAP) and (3) CARE ACT Reauthorization. Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Paulette Ford-Knights, Public Health Analyst, National Center for HIV, STD, and TB Prevention, 1600 Clifton Road, NE., Mailstop E-07, Atlanta, Georgia 30333. Telephone 404/639-8008, fax 404/639-3125, e-mail email@example.com.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: March 10, 2003.
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 03-6266 Filed 3-14-03; 8:45 am]
BILLING CODE 4163-18-P